References
- Anstey AV, Hift RJ. (2007). Liver disease in erythropoietic protoporphyria: insights and implications for management. Gut 56:1009–18
- Baldwin CM Jr, Kaplan EN. (1983). Silicone-induced human adjuvant disease. Ann Plast Surg 10:270–3
- Bloomer JR. (1997). Hepatic protoporphyrin metabolism in patients with advanced protoporphyric liver disease. Yale J Biol Med 70:323–30
- Cassidy SL, Dotti A, Kolesar GB, et al. (2001). Hexamethyidisiloxane: a 13-week subchronic whole-body vapor inhalation toxicity study in Fischer 344 rats. Int J Toxicol 20:391–9
- Clegg ED, Cook JC, Chapin RE, et al. (1997). Leydig cell hyperplasia and adenoma formation: mechanisms and relevance to humans. Reprod Toxicol 11:107–21
- Cook JC, Klinefelter GR, Hardisty JF, et al. (1999). Rodent Leydig cell tumorigenesis: a review of the physiology, pathology, mechanisms, and relevance to humans. Crit Rev Toxicol 29:169–261
- Dobrev ID, Reddy MB, Plotzke KP, et al. (2003). Closed-chamber inhalation pharmacokinetic studies with hexamethyldisiloxane in the rat. Inhal Toxicol 15:589–617
- Dourson ML, Felter SP, Robinson D. (1996). Evolution of science-based uncertainty factors in noncancer risk assessment. Regul Toxicol Pharmacol 24:108–20
- Dow Corning Corporation. (1996). An acute whole body vapor inhalation toxicity study with hexamethyldisiloxane in albino rats. Report #1996:I0000–41477
- Dow Corning Corporation. (1998). A thirteen week whole body vapor inhalation study of hexamethyldisiloxane (HMDS) in Fischer344 rats. Report #1998:I0000–44303
- Dow Corning Corporation. (2002). A one-week vapor inhalation study to evaluate by immunohistochemistry the effect of hexamethyldisiloxane (HMDS) on alpha 2u-globulin accumulation in the kidneys of male Fischer 344 rats. Report #2002:I0000–51723
- Dow Corning Corporation. (2004a). An acute whole body inhalation toxicity study of octamethyltrisilocane in rats. Report #2004:I0000–54030
- Dow Corning Corporation. (2004b). Hexamethyldisiloxane: a 24-month combined chronic toxicity and oncogenicity whole body vapor inhalation study in Fischer344 rats. Report #2004:I0000–53896
- Dow Corning Corporation. (2006). An inhalation two-generation reproductive toxicity study of hexamethyldisiloxane (HMDS) in rats, including developmental neurotoxicity assessment of the F2 generation. Report #2006:I0000–56321
- Dow Corning Corporation. (2007a). Combined repeated dose toxicity study with the reproductive/developmental toxicity screening test for decamethyltetrasiloxane (L4) in Sprague-Dawley rats via inhalation exposure. Report #2007:I0000–58160
- Dow Corning Corporation. (2007b). Combined repeated dose toxicity study with the reproductive/developmental toxicity screening test for octamethyltrisiloxane (L3) in Sprague-Dawley rats via inhalation exposure. Report #2007:I0000–58159
- Dow Corning Corporation. (2008). An inhalation two-generation reproductive toxicity study of hexamethyldisiloxane (HMDS) in rats, including developmental neurotoxicity assessment of the F2 generation -- Amendment to report number 2006:10000–56321. Report #2008:I0000–59215
- Dow Corning Corporation. (2010a). A 90-day subchronic whole body inhalation toxicity study of decamethyltetrasiloxane (L4) with a 28-day recovery period in Sprague-Dawley Rats. Report # 2010:I0000–62271
- Dow Corning Corporation. (2010b). 90-day whole body inhalation toxicity study of octamethyltrisiloxane (L3) in the rat. Report #2010:I0000–62889
- Dow Corning Corporation. (2012). Investigating the mode of action of protoporphyrin accumulation in Sprague-Dawley Rats. Report # 2012:I0000–65978
- Farland W, Dourson M. (1992). Comparative environmental risk assessment. Boca Raton, LA: Lewis Publishers
- Hazardous Substance Data Bank (HSDB). (2006). Hexamethyldisiloxane (CASRN: 107-46-0). Available from: http://toxnet.nlm.nih.gov/help/hsdbnames.html [Last accessed: 21 Jan 2012]
- Henderson RF, James JT. (1994). Octamethyltrisiloxane. In: National Research Council's Committee on Toxicology (ed.). Spacecraft maximum allowable concentrations for selected airborne contaminants, Volume 1. Washington, DC: National Academy Press, 169–75 . Available from: http://www.nap.edu/openbook.php?record_id=9062&page=R1
- Horii Y, Kannan K. (2008). Survey of organosilicone compounds, including cyclic and linear siloxanes, in personal-care and household products. Arch Environ Contam Toxicol 55:701–10
- Isquith A, Matheson D, Slesinski R. (1988). Genotoxicity studies on selected organosilicon compounds: in vitro assays. Food Chem Toxicol 26:255–61
- James JT, Gardner DE. (1996). Exposure limits for airborne contaminants in spacecraft atmospheres. Appl Occup Environ Hygiene 11:1424–32
- James JT, Limero TF, Beck SW, et al. (2003). Toxicological assessment of the International Space Station atmosphere with emphasis on metox canister regeneration. SAE International. Report No. 2003-01-2647
- James JT, Limero TF, Leano HJ, et al. (1994). Volatile organic contaminants found in the habitable environment of the Space Shuttle: STS-26 to STS-55. Aviat Space Environ Med 65:851–7
- Knasmuller S, Parzefall W, Helma C, et al. (1997). Toxic effects of griseofulvin: disease models, mechanisms, and risk assessment. Crit Rev Toxicol 27:495–537
- Lavigne JA, Nakatsu K, Marks GS. (2002). Identification of human hepatic cytochrome P450 sources of N-alkylprotoporphyrin IX after interaction with porphyrinogenic xenobiotics, implications for detection of xenobiotic-induced porphyria in humans. Drug Metab Dispos 30:788–94
- Liebich HM, Bertsch W, Zlatkis A, et al. (1975). Volatile organic components in the Skylab 4 spacecraft atmosphere. Aviat Space Environ Med 46:1002–7
- McMullin TS, McNett DA, Durham J, et al. (2013). A physiologically based pharmacokinetic model to describe the disposition of hexamethyldisiloxane, a linear volatile methyl siloxane (VMS), following inhalation exposures in the rat. Toxicologist 132:132
- NRC National Research Council (NRC). (1992). Guidelines for developing spacecraft maximum allowable concentrations for Space Station contaminants. Washington, DC: National Academy Press
- Rowe VK, Spencer HC, Bass SL. (1948). Toxicological studies on certain commercial silicones and hydrolyzable silane intermediates. J Ind Hyg Toxicol 30:332–52
- Swenberg JA. (1993). Alpha 2u-globulin nephropathy: review of the cellular and molecular mechanisms involved and their implications for human risk assessment. Environ Health Perspect 101:39–44
- United States Environmental Protection Agency (USEPA). (1994). Methods for derivation of inhalation reference concentration and application of inhalation dosimetry. Report #EPA/600/8-90/006F
- Varga J, Schumacher HR, Jimenez SA. (1989). Systemic sclerosis after augmentation mammoplasty with silicone implants. Ann Intern Med 111:377–83
- Wagner V. (2008). Bacterial Reverse Mutation Assay, BioReliance, Study #AC09FV.503.BTL
- Yoshida SH, Chang CC, Teuber SS, et al. (1993). Silicon and silicone: theoretical and clinical implications of breast implants. Regul Toxicol Pharmacol 17:3–18